Spain Respiratory Devices Market: Market Size & Forecast 2026

Spain's respiratory devices market sits within the broader European medical equipment industry and serves both hospital and home-care settings. Independent estimates place 2025 market value between USD 430 million and USD 640 million, with most projections clustering around the USD 570-640 million range and a compound annual growth rate of roughly 5-7%. Public bodies such as INE, Eurostat, and AEMPS provide contextual health and regulatory data, but do not publish specific commercial market sizing in U.S. dollars.

• •2025 market size estimated at approximately USD 0.57 billion, with a CAGR near 6.0%.
• •Forecast values diverge by source, ranging from USD 687 million to USD 933 million by the early 2030s.
• •Demand spans therapeutic devices (ventilators, CPAP/BiPAP, oxygen therapy) and monitoring/diagnostic equipment.

Demographic aging is the most consistent structural driver, as Spain has one of the highest shares of residents aged 65 and over in Europe, increasing the pool of patients with chronic respiratory disease. Rising diagnosis rates of COPD, asthma, and obstructive sleep apnea, alongside greater clinical acceptance of home-based ventilation and oxygen therapy, are expanding the addressable patient population. Additional support comes from Spain's publicly funded national health system, which reimburses a growing list of respiratory therapies and home-care equipment.

• •Spain's aging population is lifting the prevalence of chronic respiratory conditions.
• •Increased awareness and diagnosis of sleep apnea is boosting demand for CPAP and BiPAP devices.
• •Public reimbursement for home respiratory therapy is supporting equipment adoption outside hospitals.

The market is commonly segmented by device type into therapeutic devices (ventilators, positive airway pressure devices, oxygen concentrators, nebulizers, humidifiers) and monitoring/diagnostic devices (spirometers, pulse oximeters, capnographs, polysomnography systems). Therapeutic devices hold the larger share, driven by the high installed base of PAP machines and oxygen systems for long-term care. Geographically, demand is concentrated in Spain's most populous and economically active regions, including Catalonia, Madrid, Andalusia, and the Valencian Community, where major hospital networks and private home-care providers are headquartered.

• •Therapeutic devices (PAP, ventilators, oxygen therapy) account for the majority of revenue.
• •Monitoring and diagnostic devices form a smaller but faster-growing segment tied to earlier detection.
• •Catalonia, Madrid, Andalusia, and the Valencian Community are the leading regional markets.

What are the recent trends and outlook?

The most visible trend is the continued shift of respiratory care from hospitals into the home, supported by smaller, quieter, and connected PAP and ventilation devices. Manufacturers are increasingly integrating remote monitoring and telehealth-compatible data platforms, enabling clinicians to track adherence and therapy outcomes. Looking ahead, the market is expected to keep expanding at a mid-single-digit pace, with growth tilting toward connected, home-based, and personalized respiratory solutions that align with Spain's cost-efficiency goals in chronic disease management.

• •Home-based ventilation and oxygen therapy are the fastest-expanding subsegments.
• •Connectivity and remote patient monitoring are becoming standard features in new PAP and ventilator platforms.
• •Long-term outlook remains positive, with sustained mid-single-digit growth driven by aging demographics and chronic disease prevalence.